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The cyclin kinase inhibitor p21 associates with and inhibits cyclin–CDKs to retard the progress of the cell cycle in response to DNA
damage. The recognition sites for cyclin binding on the various cell cycle-related molecules have been identified as RXL motifs. In the case
of p21, the dependence of the Cy1 (18CRRL) or Cy2 (154KRRL) motifs on cyclin E, but not on cyclin A has been demonstrated by in vitro
experiments. In this study, to clarify the mechanism of p21 association with cyclin A, we constructed a p21 expression system in mammalian
cells. After transfection with an expression vector containing cDNA of various p21-mutants, cells were irradiated with 10 Gy of g-rays to
introduce DNA damage, followed by quantification of the p21-cyclin A association. The p21-mutant constructs were single or multiple
deletions in Cy1, Cy2, and the CDK2 binding region, and a nonphosphorylatable alanine mutant of the C-terminal phosphorylation site. We
demonstrated that the association of p21 and cyclin A in response to g-irradiation requires the CDK binding region, 49–71 aa, but not the Cy
motifs. We believe the mechanism by which p21 inhibits cyclin–CDKs is distinct in each phase of the cell cycle. Furthermore, the increase in
the association of p21 and cyclin A was not correlated with the levels of p21. This suggests that DNA damage triggers a signal to the p21
region between 21 and 96 aa to allow cyclin A association.
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1. Introduction identified in the cyclin kinase inhibitors [4], the CDC25aWhen DNA damage is incurred in proliferating cells, cell
cycle progression is retarded through the inhibition of CDKs
by cyclin kinase inhibitors. The cyclin kinase inhibitor p21
associates with cyclin E–Cdk2 to cause G1/S arrest, with
cyclin A–CDK2 to cause S phase retardation, and with
cyclin A–CDC2 to cause G2/M arrest [1–3].
In order to document the cellular response to DNA
damage, it is necessary to clarify the mechanisms used for
the association of cyclin–CDKs and inhibitors. A Cy or
RXL motif, arginine-hydrophobic residue—leucine, was0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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E-mail address: kfukuchi@med.showa-u.ac.jp (K. Fukuchi).phosphatase [5], direct substrates of CDKs, p107, p130 and
pRB [6–8], and other targets of cyclin–CDK complexes,
such as Myt1 to cyclin B–CDC2 [9], SSeCKS to cyclin D
[10], CDC6 to cyclin A–CDK2 [11–13], human papillo-
mavirus E1 protein to cyclin E–CDK2 [14] and h3-endo-
nexin to cyclin A [15].
As for p21, the N-terminal 1–82 aa region was reported
from in vitro experimentation to be essential for the inhibi-
tion of cyclin–CDK, and for its association with cyclin A,
cyclin E, or CDK2 in an uncoupled form or a complex form
[16]. Recently, Wohlschlegel et al. [17] reported that while
cyclin E associates with p21 through the Cy motif, cyclin A
does not, from studies demonstrating that the Cy-deleted
mutant-p21 precipitated the cyclin A–CDK2 and that p21
treated with anti-Cy motif antibody coprecipitated with
cyclin A–CDK2.
K. Fukuchi et al. / Biochimica et Biophysica Acta 1642 (2003) 163–171164The interaction of the p21-related CDK inhibitor, p27,
and cyclin A is mediated by an RNLFG sequence in p27
that interacts with a hydrophobic groove on the surface of
cyclin A [18,19]. Although p21 and p27, as members of the
Cip/Kip family, have common structures and functions, their
mechanisms for cell cycle inhibition may differ. Therefore,
the molecular mechanisms mediating the association of
cyclin A–CDK2 and p21 should be defined.
In this study, we constructed a eukaryotic expression
system using various p21-deletion mutants, including dele-
tions in the Cy1, Cy2 and CDK2 binding regions. We
irradiated those p21 mutant expressing cells with g-rays
and analyzed the association of p21-cyclin A–CDK2. Our
results show that the association of p21 with cyclin A in
response to g-irradiation requires the CDK2 binding region,
but not the Cy motif.2. Materials and methods
2.1. Generation of expression plasmids
The DNA fragments coding truncated p21 fragments
were propagated by PCR using a p21 cDNA clone, as
described previously [20,21]. The generated fragments
were inserted into either pcDNA3.1/His or pcDNA3.1/
Myc–His vectors (Invitrogen, CA) and transfected into
JM109 according to the manufacture’s instruction. The
transfectants were propagated and extracted, as described
previously [22]. A portion of the plasmid DNA (3 Ag) was
digested with 6 units of SalI restriction endonuclease for
use in DNA sequencing. Sequencing reactions were per-
formed by the dideoxynucleotide termination method using
the T7 universal primer. Results were analyzed by an ALF
sequencer (Pharmacia, Sweden), as described previously
[23]. The sequence obtained was compared with the p21
cDNA sequence to confirm that the correct clone was
constructed.
2.2. Expression of p21 mutant
The DLD-1 human colon cancer cell line from the
Health Science Research Resource Bank was used for
expression of the truncated p21 fragments. The cells were
cultured in RPMI1640 containing 10% fetal calf serum
(FCS) at 37 jC in a humidified 5% CO2 incubator. Cells
were seeded into 10-cm-diameter dishes at 1106 cells
per dish, and passaged every third day. Exponentially
growing cells (2 107) were harvested, washed with ice-
cold phosphate buffered saline (PBS), and then resus-
pended in 0.5 ml of DMEM without FCS on ice for 5
min. Cell suspensions were transferred to electroporation
cuvettes (BioRad, CA) that were chilled on ice. Super-
coiled plasmid DNA (150 Ag) was added to the cell
suspension, and the mixture was incubated on ice for 5
min. Electroporation was performed at 250 V with a 1000AF capacitor. After electroporation, the cuvette was placed
on ice for 5 min. Transfected cells were diluted into 10 ml
RPMI1640 with 10% FCS, and cultured at 37 jC in a
humidified 5% CO2 incubator for 48 h. g-irradiation was
performed at room temperature using a Gammacell 3000
Elan (Nordion International, Canada) with a 137Cs source
emitting at a fixed dose rate of 2.7 Gy min 1.
2.3. Protein extraction and Western blot analysis
A total of 2 107 cells were harvested by trypsinization,
washed with PBS and then lysed in 3 ml of 2 10 2 M
sodium phosphate, 5 10 1 M NaCl pH 7.8, 5 Ag/ml
leupeptin, and 5 Ag/ml aprotinin. The lysate was homoge-
nized by sonication at 100 W for 10 s on ice. Approximately
100 Al of a 50% slurry ProBond resin (Invitrogen) was
added to the lysate, and the mixture was rocked gently for 1
h at 4 jC. The resin was subjected to the following series of
washes: twice with 2 10 2 M sodium phosphate and
5 10 1 M sodium chloride pH 7.8; twice with 2 10 2
M sodium phosphate and 5 10 1 M sodium chloride pH
6.0. After washing the resin, the recombinant protein was
eluted using 5 10 1 M imidazole, 2 10 2 M sodium
phosphate, and 5 10 1 M sodium chloride pH 6.0. The
eluents were dialyzed against 5 10 3 M Tris, pH 8.0, and
concentrated by vacuum concentration.
Immunoprecipitation was performed as described pre-
viously [24]. Briefly, cells (1107) were lysed in 1 ml of
PBS with 0.1% Triton X-100, 2 Ag/ml aprotinin, and 2 Ag/
ml leupeptin, then incubated on ice for 30 min. The lysate
was clarified by ultracentrifugation at 105,000 g for 30
min at 4 jC and was immunoprecipitated with 5 Al of
anti-p21 polyclonal antibody (H164, Santa Cruz Biotech-
nology, CA) and Protein G Sepharose. For Western blot
analysis, 1% sodium dodecyl sulfate (SDS) and 2.5% h-
mercaptoethanol were added to eluents, and the mixture
was heated for 5 min at 100 jC. The denatured samples
were subjected to 10–20% SDS polyacrylamide gel elec-
trophoresis using a running buffer of 2.5 10 2 M Tris–
HCl pH 8.3, 1.92 10 1M glycine, and 0.1% SDS. The gels
were electroblotted (5 mA/cm2, 2 h) onto a polyvinylidene
difluoride (PVDF) membrane (BioRad) in a transfer buffer of
2.5 10 2 M Tris–HCl pH 8.3, 1.92 10 1 M glycine and
20% methanol. The membranes were incubated with 10%
nonfat dry milk in 110 2 M Tris–HCl pH 8.3 and
5 10 1 M NaCl (TBS) for 1 h at 25 jC, and then incubated
with either anti-p21 rabbit polyclonal antibody (1:200; H164,
Santa Cruz Biotechnology), anti-cyclin A monoclonal anti-
body (1:1000; BF683, Upstate Biotechnology, NY), anti-
cyclin E monoclonal antibody (1:1000; HE12, Santa Cruz),
anti-CDK2 polyclonal antibody (1:200; H-298, Santa Cruz),
anti-Myc monoclonal antibody (1:1000; Invitrogen), anti-
Xpress monoclonal antibody (1:1000; Invitrogen) or h-
tubulin monoclonal antibody (1:1000; 5H1 Pharmingen,
CA) diluted in TBS for 1 h at 25 jC. The blot was
washed in TBS with 0.05% Tween 20 (TTBS) to remove
K. Fukuchi et al. / Biochimica et Biophunbound antibody and incubated with a biotinylated anti-
rabbit IgG or biotinylated anti-mouse IgG in TBS for 1
h at room temperature. The membrane was again
washed in TTBS and incubated in streptavidine-biotiny-
lated alkaline phosphatase complex. After washing thor-
oughly, Nitroblue tetrazolium chloride/5-Bromo-4-chloro-
3-indolyl-phosphate substrate was used to visualize the
bands.
Each experiment was repeated at least three times. The
representative data from reproducing results is presented.3. Results
3.1. Construction of deletion fragment
To identify the region required for cyclin A binding, we
constructed various deletion mutants. The deletions were
combinations of cyclin binding motifs Cy1 18–21 aa and
Cy2 154–157 aa, the serine–proline motifs at Ser98 and
Ser130 that are phosphorylated by CDKs, and the CDKs
binding region 49–71 aa (Fig. 1). Each construct was
cloned into pcDNA3.1/His to express the N-terminal Xpress
and His-tagged fragment, or pcDNA3.1/Myc–His to ex-
press the C-terminal Myc- and His-tagged fragment.Fig. 1. Construction of p21-deletion mutants. The deletion mutants were constructe
into pcDNA3.1/His for N-terminal Xpress-His tag mutants, and pcDNA3.1/Myc–3.2. Association of cyclin A and p21 mutants increased
dose-dependently after IR and did not require Cy motifs
The N-terminal Xpress-His-tagged and C-terminal Myc–
His-tagged p21 mutants were transiently expressed in ex-
ponentially growing DLD-1 cell by electroporation. Cells
were incubated for 48 h, then irradiated with g-rays at 1, 3
or 10 Gy, followed by another 24-h incubation. The com-
parable expressions of mutant p21 in all of the transfections
were confirmed by Western blot analysis of a portion of
cells (data not shown). The expression of recombinant p21
proteins were purified by immobilized metal affinity chro-
matography using ProBond resin under native conditions.
The complex components on resin bound fractions were
dissociated by treatment with SDS and h-mercaptoethanol,
and subjected to Western blot analysis.
After g-irradiation, the association of cyclin A and full-
length p21, and N-tagged Xpress 164 and C-tagged Myc
164 were increased in a dose-dependent manner (Fig.
2A,B). Exogenously expressed C-terminal sequentially trun-
cated p21 mutants, Xpress 157 and Myc 157 (DNLS2),
Xpress 147 and Myc 147 (DCy2 and DNLS2), Xpress 128
and Myc 128 (DCy2, DNLS1,2, DPCNA and SP130), and
Xpress 96 and Myc 96 (DCy2, DNLS1,2, SP130 and SP98)
were associated with cyclin A after g-irradiation in a dose-
ysica Acta 1642 (2003) 163–171 165d by PCR using p21 cDNA as a template. Each mutant construct was cloned
His for C-terminal Myc–His tag mutants.
Fig. 2. Cyclin A or CDK2 associated with the C-terminal sequential deletion mutants. Cyclin A or CDK2 binding were examined for N-terminal Xpress tagged
(panel A) or C-terminal Myc tagged (panel B) C-terminal sequential deletion mutants. For transient expression, 150 Ag of supercoiled DNAwas electroporated
into exponentially growing 2 107 DLD-1. After 48 h cultivation, the cells were irradiated with g-rays for 1, 3, and 10 Gy, then incubated for 24 h. Cells were
lysed in native conditions, and the recombinant proteins were purified by metal affinity chromatography using ProBond, as described in Materials and methods.
Concentrated purified proteins were subjected to SDS-PAGE and Western blot analysis using anti-p21, anti-cyclin A or anti-CDK2 antibodies. Panel C: buffer
containing 0.1% Triton X-100 was used throughout the purification process.
K. Fukuchi et al. / Biochimica et Biophysica Acta 1642 (2003) 163–171166dependent manner (Fig. 2A,B). The expression levels of the
p21 mutants were comparable in unirradiated and irradiated
cells. Next, we examined the effect of various deletions of
Cy1 and Cy2 on cyclin A binding after g-irradiation with 10
Gy. The deletion mutants, Xpress D148–157C and Myc
D148–157C (DCy2), Xpress 21C (DCy1), Xpress 21–157
and Myc 21–157 (DCy1 and DNLS2), Xpress 21–147 and
Myc 21–147 (DCy1, DCy2 and DNLS2), and Xpress 21–
D148–157C and Myc 21-D148–157C (DCy1 and DCy2)were shown to associate with cyclin A (Fig. 3). These
results indicate that the association of cyclin A and p21
requires neither Cy1 nor Cy2 motifs on the p21 molecule.
Again, the expression levels of the p21 mutants in g-
irradiated and unirradiated cells were comparable.
The specificity of the cyclin A or CDK2 association with
exogenously expressed mutant p21 under the present con-
ditions for metal affinity–purification was confirmed, since
no p21, cyclin A or CDK2 was detected in the lysate of the
Fig. 3. Cyclin A or CDK2 associated with the Cy1 deletion, the Cy2 deletion or both. The requirement of Cy motifs for cyclin A or CDK2 was examined.
Xpress tagged or Myc tagged deletion mutants (Fig. 1) were expressed transiently in DLD-1 cells by electroporation using 150 Ag of supercoiled DNA. After
48 h cultivation, the cells were irradiated with g-rays for 10 Gy, and then incubated for 24 h. Cells were lysed in native conditions, and the recombinant proteins
were purified by metal affinity chromatography using ProBond as described in Materials and methods. Concentrated purified proteins were subjected to SDS-
PAGE and Western blot analysis using anti-p21, anti-cyclin A or anti-CDK2 antibodies. UT, untreated; IR, 10 Gy irradiated.
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when the 0.1% Triton X-100 containing buffer was used for
binding or washing during metal affinity purification, the
p21, cyclin A or CDK2 bands were detected, and were not
detected in the lysate of the empty vector transfection (Fig.
2C). Therefore, the detection of cyclin A or CDK2 after
metal affinity purification is specifically associated with
exogenously expressed p21.
3.3. Association of CDK2 and p21 was not changed
significantly after c-irradiation
CDK2 was detected on the exogenously expressed full-
length p21, Xpress 164 and Myc 164 in untreated cells or
cells treated with g-irradiation (1, 3, 10 Gy) (Fig. 2A,B).
The g-irradiation induced increases of CDK2 binding were
not as apparent as those observed with cyclin A (Fig. 2A,B).
CDK2 binding was observed in all combinations of Cy1-
and/or Cy2-deleted mutants in unirradiated and g-irradiated
cells (Figs. 2A,B and 3).
3.4. An alanine mutant at the C-terminal phosphorylation
site did not affect cyclin A binding
We examined the involvement of phosphorylation of p21
on cyclin A binding, since the significance of phosphoryla-
tion of p21 has been demonstrated previously. The phos-
phorylation of the C-terminal region of p21 during
differentiation has been proposed [25]. In addition, quite a
few phosphorylation sites and their effects have been
individually determined. For example, phosphorylation at
T145 by AKT/PKB, PKA and Pim-1, S146 by AKT/PKB,PKA and PKC, S153 by PKC and S160 by PKC have been
demonstrated to regulate subcellular localization, PCNA
binding, or degradation of p21 [26–30]. To examine wheth-
er the phosphorylation of those sites influences the binding
of cyclin A–CDK2, we constructed nonphosphorylatable
forms of alanine mutants, Xpress T145A, Xpress S146A,
Xpress TS145146AA, Xpress S153A and Xpress S160A.
The expression levels of these p21 mutants in unirradiated
and g-irradiated cells were comparable. An increase of
cyclin A binding after g-irradiation was observed in all of
the mutants at similar levels as that of wild-type p21-
expressing cells (Fig. 4).
3.5. Deletion of the CDK2 binding region (49–71 aa)
diminished the p21-binding of cyclin A and CDK2
According to the above results, cyclin A binding in
response to g-irradiation occurs regardless of whether Cy
motifs are present. We examined whether the CDK2
binding region is responsible for the cyclin A binding. In
the p21 molecule, the CDK2 binding region is located
between residues 49 and 71 or 82 [16,31,32]. We con-
structed Xpress D49–80C and Myc D49–80C, and Xpress
D49–71C and Myc D49–71C mutants (Fig. 1), and
examined their association with CDK2 and cyclin A in
unirradiated and g-irradiated cells (Fig. 5). The expression
levels of the p21 mutants in unirradiated and g-irradiated
cells were comparable. CDK2 and cyclin A bindings to the
p21 mutants were diminished in both the 49–80 and 49–
71 aa deletions (Fig. 5A), indicating that cyclin A associ-
ation with p21 in response to g-irradiation is mediated by
the CDK binding region, residues 49–71 aa. The D49–
Fig. 4. Phosphorylation at T145, S146, S153 or S160 on p21 is not required
for cyclin A or CDK2 association. The involvement of phosphorylation at
T145, S146, S153 or S160 on p21 for cyclin A or CDK2 binding was
examined. Xpress tagged T145A, S146A, TS145146AA, S153A and
S160A were expressed transiently in DLD-1 cells by electroporation using
150 Ag of supercoiled DNA. After 48 h of cultivation, the cells were g-
irradiated for 10 Gy, then incubated for 24 h. Cells were lysed in native
conditions, and the recombinant proteins were purified by metal affinity
chromatography using ProBond as described in Materials and methods.
Concentrated purified proteins were subjected to SDS-PAGE and Western
blot analysis using anti-p21, anti-cyclin A or anti-CDK2 antibodies. UT,
untreated; IR, 10 Gy irradiated.
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as observed in full-length p21, and so Cy1 and Cy2
functioned properly in those mutants. Thus, the CDK2Fig. 5. CDK2 binding region 49–71 aa is essential for the association of cyclin
region were examined for cyclin A binding. Deletion mutants, D49–80C and D49
The sequential 20 aa deletion mutants, D21–40C, D41–60C, D61–80C, and D
expression, 150 Ag of supercoiled DNAwas electroporated into exponentially grow
then incubated for 24 h. Cells were lysed in native conditions, and the recombinan
described in Materials and methods. Concentrated purified proteins were subjected
cyclin E or anti-CDK2 antibodies. UT, untreated; IR, 10 Gy irradiated.binding region, but not the Cy motifs, is required for
cyclin A binding.
To confirm the involvement of the CDK2 binding region,
we constructed sequential deletion mutants around the 49–
71 aa region (Myc D21–40C, Myc D41–60C, Myc D61–
80C, Myc D81–100C) (Fig. 1), and examined their binding
with cyclin A and CDK2. As shown in Fig. 5B, cyclin A
and CDK2 binding were not observed in the Myc D41–60C
and Myc D61–80C deletion mutants. These results suggest
that the region between 49 and 71 aa is essential for the
association of cyclin A and p21.
3.6. Association of p21 and cyclin A were confirmed by
immunoprecipitation
In order to verify the cyclin A association with p21 as
detected by the method of purification using immobilized
metal affinity chromatography, we performed the immu-
noprecipitation experiment. DLD-1 cells were transfected
with p21 mutants or empty vectors and irradiated with g-
rays at 10 Gy. Irradiated and unirradiated cell lysates were
immunoprecipitated with anti-p21 polyclonal antibody,
then subjected to Western blot analysis. A portion of each
cell lysate was applied to the Western blot and detected
with h-tubulin monoclonal antibody to confirm that the
amount of protein in each cell lysate applied for immuno-
precipitation was equivalent (Fig. 6, bottom). Exogenously
expressed p21 was detected with anti-tag antibodies, anti-
Myc or anti-Xpress antibody and were equivalent in
unirradiated and g-irradiated cells with respective trans-
fections (Fig. 6, top). The data indicate that cyclin A was
co-precipitated with the full-length p21 (Xpress 164),A and p21. Deletion mutants of the CDK2 binding region and its adjacent
–71C (Fig. 1), were expressed as Myc and Xpress tagged forms (panel A).
81–100C, were expressed as Myc tagged forms (panel B). For transient
ing DLD-1. After 48 h cultivation, the cells were g-irradiated for 10 Gy, and
t proteins were purified by metal affinity chromatography using ProBond as
to SDS-PAGE and Western blot analysis using anti-p21, anti-cyclin A, anti-
Fig. 6. Immunoprecipitation verified the requirement of the CDK2 binding region 49–71 aa for association of cyclin A and p21. The full-length p21 (Xpress
164), DCy1 (Xpress 21C and Myc 21–157), DCy2 (Myc D148–157C), DCy1DCy2 (Xpress 21–147 and Myc 21–147), the deletion of CDK2 binding region
(Xpress D49–71C and Myc D49–71C) or empty vector were electroporated into DLD-1 cells. After incubation for 48 h, cells were irradiated with 10 Gy of g-
ray (IR) or untreated (UT) followed by 24 h incubation. Cell lysates were prepared and immunoprecipitated with anti-p21 polyclonal antibody in PBS
containing 0.1% Triton X-100 and subjected to 10–20% SDS-PAGE and Western blot analysis using anti-tag antibodies (anti-Xpress or anti-Myc) to detect
exogenous p21 or anti-cyclin A antibody. To verify that equal amounts of protein were applied to the immunoprecipitation, a portion of each cell lysate was
subjected to Western blot analysis by anti-h-tubulin antibody.
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157C), DCy1DCy2 (Xpress 21–147 and Myc 21–147),
and that the band intensities of cyclin A were increased
after 10 Gy g-irradiation (Fig. 6, middle). As observed
with metal affinity purification, the deletion of CDK2
binding region (Xpress D49–71C and Myc D49–71C)
co-precipitated no cyclin A in unirradiated and very faint
band in g-irradiated cells. The intensity of the faint bands
after g-irradiation in the D49–71C transfectants was sim-
ilar to that for the empty vector transfection. Since the
anti-p21 antibody immunoprecipitates both the transfected
p21 and the endogenous p21, the faint band reflects the
cyclin A associated with the endogenous p21. Based on
the results from the immunoprecipitation experiments, we
were able to confirm that the CDK2 binding 49–71 aa
region is indispensable for the increase of cyclin A
association induced by g-irradiation.4. Discussion
In this study, we analyzed the molecular mechanisms
required for the association of p21 with cyclin A in
response to g-irradiation using a human cell line expres-
sion system. By expressing deletion mutants or site-
directed mutants of p21, we demonstrated that cyclin Abinding to p21 after DNA damage requires the CDK2 binding
domain of p21, independent of either Cy1 or Cy2 motifs. In
support of this conclusion, nonphosphorylatable mutants at
the C-terminal, i.e., T145A, S146A, S153A, and S160A,
bound to cyclin A as efficiently as wild-type p21.
In proliferating cells, cyclin A associates with CDK2
during S phase and with CDC2 during G2 phase. When
proliferating cells are exposed to a DNA damaging agent,
p21 effectively associates with cyclin A–CDK2 to retard
the progression of S phase. The mechanism of the asso-
ciation of cyclin A and p21 has been reported in both in
vitro and in vivo studies. The results of these studies
suggest that cyclin association enhances the interaction of
p21 and CDK. The information of the binding site was
provided by the cellular response to expression of p21
mutants. Amino acid residues 22–71 aa were found to be
the minimum region required for DNA synthesis inhibition
in normal human fibroblasts [32]. Wohlschlegel et al. [17]
reported that the Cy motif had little to no effect on p21’s
ability to inhibit cyclin A–CDK2 activity, although the
motif was important to inhibit cyclin E–cdk2 activity and
to the growth of mammalian cells. They also demonstrated,
through an in vitro binding study, that the Cy motif was
essential for the association of p21 with cyclin E–CDK2,
but not with cyclin A–CDK2. Furthermore, cyclin A–
CDK2 interacted with p21 predominantly through the
K. Fukuchi et al. / Biochimica et Biophysica Acta 1642 (2003) 163–171170CDK2 binding region [16]. The molar ratio of cyclin A to
p21 has been reported differently in several independent
experiments. One molecule of p21 binds with and inhibits
one cyclin A–CDK2, and is phosphorylated by CDK2 in
vitro [33,34]. On the contrary, cyclin–CDK complex was
shown to associate with multiple CDK inhibitors through
the presence of at least two binding sites in the complex
[35,36].
According to our binding analysis of the expression
system of p21 mutants, residues 21–96 were sufficient to
associate with cyclin A, which suggested that neither Cy1,
Cy2 nor NLS was necessary for the association of p21 with
cyclin A after DNA damage. Our observations are in
accordance with the previous report described above.
In the C-terminal region of p21, several phosphorylation
sites contribute to its stability, the regulation of PCNA
binding and subcellular localization [25–28,30]. All the
nonphosphorylatable p21 mutants, T145A, S146A,
TS145146AA, S153A and S160A, associated with cyclin A
after g-irradiation, similar to wild-type p21. Hence, we
conclude that the phosphorylation by AKT/PKB Pim-1 or
PKC is not a positive signal for the association of p21 and
cyclin A.
The present data generated from C-terminal deletion
mutants and nonphosphorylatable mutants of p21 expressed
in mammalian cells demonstrates that the presence of Cy
motifs and the subcellular localization of components are
unrelated to the association of cyclin A and p21 in response
to g-irradiation.
Deletion mutants of the CDK binding region, D49–
80C, D49–71C, D41–60C and D61–80C, did not associ-
ate with cyclin A–CDK2. Therefore, the region between
49 and 71 aa is necessary for the association of p21 and
cyclin A. The data agreed with the previous reports
indicating that the region between 22 and 71 aa is essential
for inhibition of DNA synthesis [32], and that cyclin A–
CDK2 interacts with p21 predominantly through the CDK2
binding region [16].
Taken together, our data indicate that the region 21–
96 aa of p21 is sufficient to associate with cyclin A–
CDK2 effectively in response to DNA damage. Since the
level of the exogenously expressed p21 mutant was
indistinguishable between unirradiated and g-irradiated
cells, the amount of available p21 is irrelevant to the
amount of associated cyclin A. Thus, the regulatory
mechanism for the association of p21 and cyclin A after
DNA damage is dependent on the 21–96 aa region.
Recent reports demonstrated that p21 was stabilized by
phosphorylation with p38 or JNK at Thr57 [37]. In
addition, phosphorylation at Thr57 by GSK3h, a down-
stream effector of AKT/PKB, was reported as a degra-
dation signal [38]. The phosphorylation status or other
modification of this region may regulate the association
of p21 and cyclin A–CDK2. Further studies are needed
to clarify the signals that regulate the association of p21
and cyclin A–CDK2.Acknowledgements
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